Effects of chemotherapeutic agent bendamustine for non-hodgkin lymphoma on spermatogenesis in mice

Abstract

Non-Hodgkin lymphoma (NHL) is one of the most common cancers affecting men of reproductive age. The high response rate of bendamustine as first-line treatment for NHL, coupled with young age of patients, makes elucidation of the impact of treatment on male reproduction important. Our aim was to determine the effects of bendamustine on male reproduction by animal model. Male mice were treated with bendamustine (40 mg/kg) through tail vein injection while cisplatin was given as a standard (3 mg/kg) through intraperitoneal injection. After 3 weeks, bendamustine induced weight loss and sperm morphology abnormalities were compared to the control. Additionally, sperm with folded tails were the most frequent abnormality in bendamustine-treated mice. But the mechanism of sperm abnormality induced by bendamustine remains to be elucidated. These results indicate bendamustine may affect spermatozoa of patients who have been treated for NHL.

Keywords

Non-Hodgkin lymphoma / chemotherapy / bendamustine / mice / spermatozoa / toxicology

References

[1] Hochberg J, El-Mallawany NK, Abla O. Adolescent and young adult Non-Hodgkin lymphoma[J]. Br J Haematol, 2016, 173(4): 637–650

[2] Bleyer A, Viny A, Barr R. Cancer in 15- to 29-year-olds by primary site[J]. Oncologist, 2006, 11(6): 590–601

[3] Jaffe ES, Harris NL, Stein H, Classification of lymphoid neoplasms: the microscope as a tool for disease discovery[J]. Blood, 2008, 112(12): 4384–4399

[4] Patte C, Auperin A, Sebban C, The 15–20 year old patients with NHL treated in France: Data of childhood and adult databases[J]. Ann Oncol, 2005, 16: 61–61.

[5] Hochberg J, Waxman IM, Kelly KM, Adolescent Non-Hodgkin lymphoma and Hodgkin lymphoma: state of the science[J]. Br J Haematol, 2009, 144(1): 24–40

[6] Becker M, Tschechne B, Reeb M, Bendamustine as first-line treatment in patients with advanced indolent Non-Hodgkin lymphoma and mantle cell lymphoma in German routine clinical practice[J]. Ann Hematol, 2015, 94(9): 1553–1558

[7] Vacirca JL, Acs PI, Tabbara IA, Bendamustine combined with rituximab for patients with relapsed or refractory diffuse large B cell lymphoma[J]. Ann Hematol, 2014, 93(3): 403–409

[8] Tageja N, Nagi J. Bendamustine: something old, something new[J]. Cancer Chemother Pharmacol, 2010, 66(3): 413–423

[9] Tageja N. Bendamustine: safety and efficacy in the management of indolent Non-Hodgkins lymphoma[J]. Clin Med Insights Oncol, 2011, 5(5): 145–156

[10] Glantz JC. Reproductive toxicology of alkylating agents[J]. Obstet Gynecol Surv, 1994, 49(10): 709–715

[11] Hales BF, Barton TS, Robaire B. Impact of paternal exposure to chemotherapy on offspring in the rat[J]. J Natl Cancer Inst Monogr, 2005, 34(34): 28–31

[12] Sawhney P, Giammona CJ, Meistrich ML, Cisplatin-induced long-term failure of spermatogenesis in adult C57/Bl/6J mice[J]. J Androl, 2005, 26(1): 136–145

[13] Bieber AM, Marcon L, Hales BF, Effects of chemotherapeutic agents for testicular cancer on the male rat reproductive system, spermatozoa, and fertility[J]. J Androl, 2006, 27(2): 189–200

[14] Ohmachi K, Niitsu N, Uchida T, Multicenter phase II study of bendamustine plus rituximab in patients with relapsed or refractory diffuse large B-cell lymphoma[J]. J Clin Oncol, 2013, 31(17): 2103–2109

[15] Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human[J]. J Basic Clin Pharm, 2016, 7(2): 27–31

[16] Us Epa O O O. Guidelines for reproductive toxicity risk assessment[J]. 1996.

[17] Hayes AW. Principles and Methods of Toxicology, Fifth Edition[J]. Crc Press, 2007.

[18] Horn U, Härtl A, Güttner J, Toxicity of the alkylating agent bendamustine[J]. Arch Toxicol Suppl, 1985, 8: 504–506

[19] Blazak WF, Ernst TL, Stewart BE. Potential indicators of reproductive toxicity: testicular sperm production and epididymal sperm number, transit time, and motility in Fischer 344 rats[J]. Fundam Appl Toxicol, 1985, 5(6 Pt 1): 1097–1103

[20] Berndtson WE. Methods for quantifying mammalian spermatogenesis: a review[J]. J Anim Sci, 1977, 44(5): 818–833

[21] Lampe H, Horwich A, Norman A, Fertility after chemotherapy for testicular germ cell cancers[J]. J Clin Oncol, 1997, 15(1): 239–245

[22] Zohni K, Zhang X, Tan SL, The efficiency of male fertility restoration is dependent on the recovery kinetics of spermatogonial stem cells after cytotoxic treatment with busulfan in mice[J]. Hum Reprod, 2012, 27(1): 44–53

[23] Brinster RL, Zimmermann JW. Spermatogenesis following male germ-cell transplantation[J]. Proc Natl Acad Sci U S A, 1994, 91(24): 11298–11302

[24] Tegelenbosch RA, de Rooij DG. A quantitative study of spermatogonial multiplication and stem cell renewal in the C3H/101 F1 hybrid mouse[J]. Mutat Res, 1993, 290(2): 193–200

[25] de Rooij DG, Russell LD. All you wanted to know about spermatogonia but were afraid to ask[J]. J Androl, 2000, 21(6): 776–798

[26] de Rooij DG. Proliferation and differentiation of spermatogonial stem cells[J]. Reproduction, 2001, 121(3): 347–354

[27] Costoya JA, Hobbs RM, Barna M, Essential role of Plzf in maintenance of spermatogonial stem cells[J]. Nat Genet, 2004, 36(6): 653–659

[28] Buaas FW, Kirsh AL, Sharma M, Plzf is required in adult male germ cells for stem cell self-renewal[J]. Nat Genet, 2004, 36(6): 647–652

[29] Harman JG, Richburg JH. Cisplatin-induced alterations in the functional spermatogonial stem cell pool and niche in C57/BL/6J mice following a clinically relevant multi-cycle exposure[J]. Toxicol Lett, 2014, 227(2): 99–112

[30] Marcon L, Zhang X, Hales BF, Effects of chemotherapeutic agents for testicular cancer on rat spermatogonial stem/progenitor cells[J]. J Androl, 2011, 32(4): 432–443

[31] Bonet S, Briz M, Fradera A, Origin, development and ultrastructure of boar spermatozoa with folded tails and with two tails[J]. Hum Reprod, 1992, 7(4): 523–528

[32] Oshio S, Tomomasa H, Amemiya H, Damaging effects of cisplatin on mouse spermatozoa[J]. Arch Androl, 1990, 24(2): 113–120

[33] Weinbauer GF, Nieschlag E. 4 – Hormonal Control of Spermatogenesis[J]. Molecular Biology of the Male Reproductive System, 1993, 99–142.

[34] Smith LB, Walker WH. Chapter 16–Hormone Signaling in the Testis[J]. Knobil & Neills Physiology of Reproduction, 2015, 637–690.

RIGHTS & PERMISSIONS

2017 2017 by the Journal of Biomedical Research.